P21 news and clinical trials
Also known as: P021 · P-21 · Peptide 021 · Ac-DGGL(A)G-NH2 · CNTF peptide mimetic
Updated 43 sources
2 new studies in the last 12 months, newest first: trial registrations and results, PubMed papers, FDA actions and press coverage that name P21. Each line links to the primary source.
April 2026
- StudyPubMedCorrigendum to Diffusion MRI measures detect brain microstructure changes due to early treatment with neurotrophic peptide mimetic P021 in the 3xTg-AD mouse model of Alzheimer's disease. Magn Reson Imaging. 2026 Jun;129:110641 Page: 9 (opens PubMed)
A corrigendum was published for a study evaluating the effects of the neurotrophic peptide mimetic P021 in the 3xTg-AD mouse model of Alzheimer's disease.
Magnetic resonance imagingPMID 41945082
February 2026
- StudyPubMedDiffusion MRI measures detect brain microstructure changes due to early treatment with neurotrophic peptide mimetic P021 in the 3xTg-AD mouse model of Alzheimer's disease (opens PubMed)
Researchers published a study using diffusion MRI to detect brain microstructure changes in the 3xTg-AD mouse model of Alzheimer's disease following early treatment with the neurotrophic peptide mimetic P021.
Magnetic resonance imagingPMID 41740658
Searched as: P021, Peptide 021, CNTF peptide mimetic. Summaries are one or two sentences, published only when every number in them appears in the source record. A tracker, not medical advice.